Quantitative LC-MS Analysis of 14 Benzodiazepines in Urine Using TraceFinder 1.1 Software and High Resolution Accurate Mass

Significance of the Topic

Determination of benzodiazepines in urine plays a crucial role in clinical research and therapeutic drug monitoring, providing insights into dosing compliance, pharmacokinetics and detection of illicit use.

Study Objectives and Overview

The study demonstrates a workflow-driven quantitative method for simultaneous analysis of 14 benzodiazepines in urine using a Thermo Scientific Exactive high-resolution mass spectrometer coupled with TraceFinder 1.1 software. The goal was to simplify routine method development, data acquisition, review and reporting within clinical research laboratories.

Methodology and Instrumentation

Sample preparation involved spiking human urine with deuterated internal standards, enzymatic hydrolysis, protein precipitation with acetonitrile, centrifugation and dilution.

• Chromatography: Thermo Scientific Hypersil GOLD PFP column (100×2.1 mm, 5 μm) at ambient temperature.
• Mass Spectrometry: Exactive benchtop HRAM, heated electrospray (HESI-II), positive mode, full-scan (m/z 135–600), resolution 100,000 FWHM, AGC target 1×10^6, max injection time 100 ms, lock mass m/z 279.2591, mass isolation window 3 ppm for compound ID.
• Software: TraceFinder 1.1 for master method creation, batch submission, real-time monitoring, data review and report generation.

Results and Discussion

TraceFinder 1.1 provided a streamlined workflow from method setup to reporting, featuring configurable tabs for configuration, method development, data acquisition and review. Performance metrics for the 14 benzodiazepines included:

• Linear range: 5–1000 ng/mL for all analytes.
• Lower limit of quantitation (LLOQ): 5 ng/mL.
• Accuracy: 85.4%–106.0%.
• Intra- and inter-batch precision (CV): 0.5%–11.7%.

Extracted ion chromatograms at the LLOQ demonstrated clear separation and sensitivity across all compounds.

Benefits and Practical Applications

The novel approach reduces software complexity by unifying instrument control and data analysis, accelerating method development and routine quantitation in clinical and research environments. Real-time status monitoring and automated reporting enhance laboratory efficiency and data integrity.

Future Trends and Opportunities

Advancements may include integration of multiplexed assays, expansion to broader analyte classes, and incorporation of machine learning for automated data review and anomaly detection, further improving throughput and robustness in clinical and forensic settings.

Conclusion

A rapid, sensitive and robust LC-HRAM method was established for quantifying 14 benzodiazepines in urine. Combined with TraceFinder 1.1 software, laboratories benefit from an intuitive, end-to-end workflow supporting high-confidence quantitation and comprehensive reporting.

Reference

• He X., Kozak M. Quantitative LC-MS Analysis of 14 Benzodiazepines in Urine Using TraceFinder 1.1 Software and High Resolution Accurate Mass. Thermo Fisher Scientific Application Note 529, 2016.